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Abstract 16 
Adult mammary stem cells (MaSCs) drive postnatal organogenesis and remodeling in the mammary gland, 17 
and their longevity and potential have important implications for breast cancer. However, despite intense 18 
investigation, the identity, location and differentiation potential of MaSCs remains subject to deliberation. The 19 
application of genetic lineage-tracing models, combined with quantitative 3-dimensional imaging and 20 
biophysical methods, has provided new insights into the mammary epithelial hierarchy that challenges 21 
classical definitions of MaSC potency and behaviors. Herein, we review recent advances—discussing 22 
fundamental unresolved properties of MaSC potency, dynamics and plasticity—and point to evolving 23 
technologies promising to shed new light on this intractable debate. An elucidation of the physiological 24 
mammary differentiation hierarchy is paramount to understanding the complex heterogeneous breast cancer 25 
landscape. 26 
  27 
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Adult mammary stem cells: concepts and challenges 28 
Adult stem cells exist in various organs, such as the intestine, skin and skeletal muscle [1,2]. In these tissues, 29 
their primary role is homeostatic, that is, to replenish cells lost to attrition or injury. However, unlike many 30 
other organs, the mammary gland primarily develops postnatally [3,4] (Figure 1), and thus stem cells in the 31 
adult mammary gland serve both developmental and homeostatic functions.  32 
 33 
Construction of the branching ductal epithelium during puberty is driven by hormones, growth factors and 34 
local signaling cues, and proceeds via proliferation of mammary stem cells (MaSCs, see Glossary) and their 35 
progeny within bulbous distal structures known as terminal end buds (TEBs) (Figure 1b) [5,6]. By the end 36 
of puberty, ductal morphogenesis is complete and the TEBs have fully regressed (Figure 1c) [4]. Although it 37 
is generally accepted that stem cells persist in the adult mammary gland following the demise of the TEBs—38 
where they have essential roles in the generation and regeneration of the alveolar (milk-producing) epithelium 39 
during pregnancy and lactation (Figure 1c-f)—the location of these cells within the complex ductal epithelium 40 
remains elusive [6,7]. Additionally, despite intense investigation and debate, the differentiation potential of 41 
adult MaSCs (i.e. their ability to generate one or both of the mammary epithelial cell lineages) remains 42 
contentious [7–18]. The longevity and extensive self-renewal properties of these cells, however, place them 43 
as probable candidates for oncogenic transformation in some breast cancers [19,20]. Moreover, some breast 44 
cancers may be hierarchically-organized and contain a pool of cancer stem cells that drive their precipitous 45 
and long-term growth and regrowth [19–21]. Thus, a greater understanding of the identity, plasticity and 46 
differentiation potential of adult MaSCs, and the specific pathways that regulate their self-renewal and fate, 47 
may also provide important insights into the heterogeneity and treatment resistance of this intractable disease. 48 
 49 
Recent studies, using single cell lineage-tracing approaches, have revealed the immense capacity of a single 50 
MaSC to contribute to the formation of the ductal epithelium during puberty [16,18] and the alveolar 51 
epithelium during pregnancy/lactation [16]. These studies also highlight considerable redundancy within this 52 
system [16,18], positing that several hundred lineage-restricted MaSCs actively and stochastically contribute 53 
to ductal and alveolar morphogenesis under physiological conditions. This is not entirely surprising, given 54 
that lactation is an evolutionarily essential aspect of mammalian survival that demands functional stem cells. 55 
However, if MaSCs are the cell-of-origin in some breast cancers, then this superfluity brings with it a heighted 56 
opportunity for oncogenic transformation. Regardless, the inextricable connections between MaSCs and breast 57 
cancer warrants further investigation, to achieve a unified and enduring characterization of their potential, 58 
anatomical location and molecular profile. 59 
 60 
Here, we discuss recent insights into the mammary epithelial cell hierarchy, addressing unanswered 61 
questions relating to MaSC potency, dynamics and plasticity. We discuss the unique challenges in elucidating 62 
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the mammary epithelial cell hierarchy and highlight evolving technologies that promise to shed new light on 63 
these difficult questions. 64 
 65 
The epithelial cell hierarchy: an evolving paradigm 66 
In 1959, a seminal study published in Cancer Research demonstrated that fragments of mammary tissue could 67 
be transplanted into the epithelium-divested fat pad of a recipient mouse, successfully engraft, and generate 68 
an entire ductal epithelium anew [22]. What followed was a divisive pursuit to identify and characterize the 69 
cells responsible for the development, maintenance and regeneration of the mammary epithelium (i.e. adult 70 
MaSCs) that has lasted for more than 50 years (Figure 2). Transformative advances came on the back of at 71 
least three key enabling methodologies: the isolation of cells with enhanced repopulating and self-renewal 72 
properties upon transplantation; population-based genetic fate-mapping; and stochastic, single cell genetic 73 
lineage-tracing. The ability to image ducts and alveoli in three- [14–16,18,23,24] or four-dimensions [18] 74 
(Box 1), combined with quantitative image analysis and biostatistical modeling [5,15,18], has also provided 75 
important insights into clonal dynamics and dispersion patterns that could not have been attained through the 76 
examination of thin tissue sections [25]. Here, we broadly examine these techniques, summarizing key 77 
findings with a retrospective wisdom. 78 
 79 
Transplantation  80 
The observation that any fragment of mammary tissue has the potential to regenerate the entire bilayered 81 
mammary epithelium upon serial transplantation provided strong evidence that mammary repopulating cells 82 
(believed to be bona fide MaSCs) were distributed throughout the length of the adult ductal epithelium [26–83 
28]. Subsequent work using retroviral-tagged mammary tissue fragments [29] and limiting dilutions of 84 
heterogeneous cell suspensions confirmed these results [30,31], and these studies were in-turn refined and 85 
expanded by the identification and purification of a subset of cells with superior repopulating capacity [8–10] 86 
(Figure 2). Collectively, these analyses supported the notion that adult MaSCs were bi/multipotent. The 87 
demonstration that lineage-restricted cells could be forced to adopt a multipotent fate under “regenerative 88 
conditions” [11–13] challenged this dogma. It is now widely accepted that mammary repopulating cells, 89 
identified by transplantation, are distinct from stem cells that exist under physiological conditions. 90 
Nevertheless, this technique has provided some important insights into qualities of self-renewal and 91 
regeneration, with enduring relevance. 92 
 93 
Population-based genetic fate-mapping 94 
The application of genetic lineage-tracing techniques to mammary tissue has enabled temporal examination 95 
of lineage relationships under physiological conditions. These studies have utilized tamoxifen- or 96 
doxycycline- responsive transgenic mouse models to induce the expression of reporter genes in predefined 97 
cohorts of cells [11–15,17]. The genetic label, typically a fluorescent or histochemical reporter, is permanently 98 
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expressed by the original cell and is transmitted to all of its progeny. An analysis of reporter expression 99 
through time can be used to determine whether the original labeled population contained lineage-restricted 100 
stem cells or cells with multi-lineage differentiation potential (Figure 2). In its original application in the 101 
mammary gland [11], this approach was used to track the fate of luminal cells (e.g., cytokeratin (K)8-102 
expressing) and basal cells (e.g., K14-expressing), demonstrating that lineage-restricted MaSCs drive 103 
postnatal mammary gland development and maintenance. Subsequent lineage-tracing studies have provided 104 
evidence in support of both unipotent and bi/multipotent adult MaSCs [12–15,17,32] (Figure 2). Lineage-105 
restricted cell populations have also been shown to convert to multipotency in vivo by oncogenic PI3KCA 106 
signaling, suggesting that there is scope for plastic transformation and thereby adding further complexity to 107 
this system [33,34]. 108 
 109 
Inconsistencies in recent lineage-tracing studies in the normal mammary gland may be in-part attributable to 110 
the temporal expression of pathway-specific promoters [12,13] or the fidelity of pan-lineage promoters. Given 111 
that a single mammary stem/progenitor cell is capable of producing many hundred progeny [16], the 112 
promiscuous labeling of even a small number of cells of the opposing lineage could significantly confound 113 
downstream lineage analysis in this model [15,16]. A second limitation relates to the power of population-114 
based labeling approaches to accurately detect single clone expansion, which is a function of both the method 115 
of detection and the initial labeling density (Figure 3). To overcome this problem, as well as potential tracing 116 
artefacts associated with the preferential labeling of specific (and potentially non-representative) cell sub-117 
populations, a recent study has mapped the fate of all basal cells (a technique termed saturation lineage-118 
tracing) [15]. If rare bipotent MaSCs do reside in the basal compartment and contribute even minimally to 119 
mammary gland morphogenesis and homeostasis [1], this could be detected by an increase in the number of 120 
fluorescently-labeled luminal cells, observed using both fluorescence activated cell sorting or 3D image 121 
quantification. No population flux was detected using either method of analysis in these studies, suggesting 122 
that basal MaSCs are indeed lineage-restricted [15]. A subsequent report [35], however, demonstrated that 123 
enzymatic digestion prior to 3D imaging [15,18,36,37] can deplete or structurally damage basal cells, 124 
postulating that rare bi-lineage clones are not detected under these conditions [35]. Recently described 125 
methods for non-proteolytic 3D imaging [16,24], together with quantitative platforms for image analysis, 126 
which consider tissue architecture, cell morphology, chimerism and Cre-specificity [15,35], will undoubtedly 127 
aid future lineage tracing studies in the mammary gland. 128 
 129 
Stochastic, single cell genetic lineage-tracing 130 
Lineage-tracing has facilitated in situ examination of MaSC properties under conditions of minimal 131 
interference. However, unlike transplantation assays, these studies have been unable to map the fate of a single 132 
labeled cell [9]. Obstacles to single cell genetic lineage-tracing have, however, been mitigated in-part by 133 
advances in whole-organ clearing [24] and high-resolution 3D imaging [14] (Box 1).  134 
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 135 
Recently, R26[CA]30 mice [38] have been used to achieve unbiased labeling of single proliferating cells in the 136 
mammary gland [16]. Genetic labeling in this model is exceedingly rare, and thus it can be combined with 3D 137 
imaging to track the fate of a single labeled cell with confidence (Figure 2). A similar approach to achieve 138 
low-density, unbiased labeling involves the use of mice that express inducible Cre-recombinase in all cells 139 
(R26CreERT2). Neutral, multi-color labeling is achieved by crossing these mice with R26Confetti animals, and 140 
sparse reporter induction is attained using low doses of tamoxifen [16,18]. Recent application of these models 141 
has provided further evidence that unipotent MaSCs drive ductal morphogenesis during puberty [16,18] and 142 
alveolar morphogenesis during gestation [16]. However, whilst the small number of cells initially labeled in 143 
these models permit the indisputable analysis of clonal progeny, it also limits their power to detect and 144 
characterize the full spectrum of stem and progenitor cells present in the mammary epithelium. For example, 145 
quiescent bi/multipotent MaSCs, if they exist, would not be detected by this approach [16].  146 
 147 
Single cell lineage-tracing has unquestionably demonstrated the immense capacity of unipotent stem cells to 148 
contribute to the development of the adult mammary epithelium, whilst at the same time revealing significant 149 
redundancy in the construction of each major duct [16,18] and lobuloalveolar structure [16]. Whether adult 150 
stem cells work cooperatively or competitively to achieve developmental and morphogenetic outcomes in the 151 
mammary gland is an area of active investigation and is discussed in more detail later in this review. 152 
 153 
Multiplicity in the mammary gland: roles for potential and quiescent stem cells  154 
In addition to the cells that are responsible for the genesis and expansion of the mammary epithelium (known 155 
as professional, functional or bona fide stem cells), there may also exist a population of cells in the adult breast 156 
with the capacity to behave as stem cells under certain conditions (i.e. facultative or potential stem cells) 157 
[1,39]. This may include 1) a subset of cells that remain quiescent during normal tissue development, and 2) 158 
cells that are recruited under regenerative conditions [9,11,40] or in cancer [33,34]. Support for a cellular 159 
arrangement in the breast that departs from a unidirectional, top-down model is given by transplantation 160 
studies. Although it is now generally accepted that mammary repopulating cells are activated under non-161 
homeostatic conditions [11–13], the underlying experimental observation (i.e. that not all cells are capable of 162 
repopulating the empty fat-pad [8–10]) points to the existence of a population of cells that have an intermediate 163 
or plastic nature. The physiological and pathological role of these cells, and their relationship to putative 164 
populations of quiescent MaSCs, is not immediately apparent (Figure 4). However, the notion that fate 165 
decisions within the hierarchy are not strictly unidirectional, and in some conditions could be reversed, has 166 
wide-reaching implications for oncology and regenerative medicine. 167 
 168 
A putative population of quiescent MaSCs 169 
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A pool of quiescent stem cells, which have temporarily and reversibly exited the cell cycle, has been observed 170 
in various self-renewing tissues, including the skin [41–43] and intestine [44]. These cells may be able to re-171 
enter the cell cycle when required, for example upon injury [45] or homeostasis [46]. Quiescent stem cells are 172 
unlikely to be detected by conventional lineage-tracing approaches, which require proliferation for clone 173 
identification [47]. As such, label-retention assays have been developed for the analysis of slow-cycling and 174 
quiescent cells [48]. DNA-intercalating nucleosides (e.g., BrdU/EdU and [3H]-thymidine) can be used to label 175 
cells that are in cycle at the time of the pulse [47]. Alternatively, a GFP-labeled histone H2B model could be 176 
used to label specific populations of cells, with expression of H2B-GFP temporally-moderated by 177 
administration of doxycycline [43,48,49]. Cells that remain labeled after a pre-determined chase, known as 178 
label-retaining cells, are presumed to be slow-cycling/quiescent stem cells, but may also be long-lived 179 
terminally-differentiated cells [48]. Application of the H2B-GFP model to the mammary gland has identified 180 
a novel population of Cd1d+ cells with enhanced repopulating ability upon transplantation [49]. Cd1d+ 181 
mammary repopulating cells are also enriched for Bcl11b expression, a C2H2 zinc finger transcription factor 182 
that has independently been shown to be associated with physiological quiescence and superior repopulating 183 
activity under transplantation conditions [50]. Interestingly, neither Cd1d nor Bcl11b mRNAs are enriched in 184 
the recently-identified quiescent basal cell population defined by Lgr5 and Tspan8 expression [51]. These 185 
Lgr5+Tspan8hi basal cells, located within the proximal ductal tree, were also demonstrated to have enhanced 186 
repopulating activity in limiting dilution transplantation assays [51]. Thus, these data suggest significant 187 
multiplicity, even within the putative subset of quiescent mammary repopulating cells. 188 
 189 
Unanswered questions: organization, function and recruitment  190 
The proliferative demand on mammary stem and progenitor cells throughout reproductive life is substantial 191 
(Figure 1) [3,4]. Thus, the relative importance of quiescent MaSCs in normal development and homeostasis 192 
is unclear. How quiescent and potential stem cells may be recruited by specific signals in the 193 
microenvironment, and their hierarchical relationship to functional stem cells is also shrouded in uncertainty. 194 
In light of the ongoing debate regarding the identity and potency of MaSCs [11–18], the fundamental 195 
requirement for proliferation for clone detection in lineage-tracing studies [47], and the idea that quiescent 196 
stem cells may reside at the apex of tissue hierarchies [49], one could reasonably suggest that there may be a 197 
residual population of quiescent bi/multipotent MaSCs that remain in the postnatal mammary gland after 198 
embryonic development (Figure 4). In utero DNA-labeling has provided some support for this hypothesis, 199 
identifying long-lived label-retaining cells that are able to reversibly re-enter the cell cycle and contribute to 200 
tissue development and maintenance [46]. More-recent saturation lineage-tracing, which has been able to label 201 
more than 95% of all cells within a single lineage, however, indicates that quiescent MaSCs (if they exist and 202 
participate in any way to tissue development and/or homeostasis), are lineage-restricted [15]. Analysis of cell 203 
division kinetics and telomere lengths in mammary epithelial populations also suggests that that each lineage 204 
is maintained by its own precursors throughout reproductive life [52]. 205 
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 206 
A number of important questions in this area remain unanswered. However, given the complex cellular 207 
heterogeneity in breast cancer, a long-lived and highly plastic stem cell could serve as a potential cell-of-origin 208 
for this disease. This highlights the importance of determining the full landscape of MaSC populations and 209 
the factors regulating their recruitment. 210 
 211 
The mammary stem cell niche: an elusive entity or dynamic force? 212 
The ability of MaSCs to rapidly and faithfully respond to developmental and homeostatic demands throughout 213 
reproductive life may be attributable to their intimate association with a specific cellular microenvironment, 214 
known as the mammary stem cell niche. Stem cell niches can embody discrete and highly-specialized sites in 215 
certain tissues, e.g., the crypt base of the small intestine and the hair follicle [2]. Other tissues, including the 216 
post-pubescent mammary gland, prostate and lung, lack an easily-discernable niche, and stem cells in these 217 
organs may instead respond to more-ubiquitous tissue signals [2]. In any case, reciprocal interactions between 218 
MaSCs and their mature epithelial progeny, neighboring stromal cells and the supporting extracellular matrix, 219 
undoubtedly provide the autocrine, juxtracrine and paracrine signals that direct and adjust cell fate [19]. 220 
Extrinsic regulatory cues may include diffusible molecules (e.g., growth factors and cytokines) as well as 221 
mechanical forces (e.g., cell-cell and cell-matrix interactions) [53,54]. In this section, we outline designs of 222 
mammary stem and progenitor cell distribution in the pubescent, mature and secretory epithelium, discussing 223 
how the spatial arrangement of these cells may underpin the development and integrity of this highly dynamic 224 
tissue. 225 
 226 
Architectural conceptions of a MaSC niche 227 
The absence of a definitive molecular portrait of MaSCs, combined with uncertainties regarding their precise 228 
location within the post-pubescent mammary epithelium, has greatly impeded the analysis of prospective 229 
MaSC niches. Cell surface signatures that facilitate the isolation of mammary repopulating cells also provide 230 
little insight into the tissue-positional cues that direct cell behavior. Early transplantation and ultrastructural 231 
studies, however, did imply that mammary repopulating cells were distributed throughout the ductal 232 
epithelium [26–28,55], positing that MaSC niches may reside in a “suprabasal” location in the epithelial 233 
bilayer [27,56,57].  234 
 235 
Although the precise location of stem cells within the post-pubescent breast remains unclear (Figure 1c), it is 236 
generally accepted that the TEBs of elongating ducts serve as a transient niche during puberty (Figure 1b) 237 
[5,19]. Thus, a comprehensive examination of signaling events in TEB-resident stem cells is expected to yield 238 
important insights into the pathways directing MaSC activity and fate, which may also be relevant in the post-239 
pubescent gland. TEBs consist of an outer layer of cap cells that envelop multiple layers of inner body cells 240 
[3]. Cap and body cells are generally considered to be the precursors of mature basal and luminal epithelial 241 
8 
 
lineages, respectively [19]. Cap cells have also long been hypothesized to represent an enriched population of 242 
bi/multipotent MaSCs [27,58,59]. Indeed, the stem cell associated phosphatase gene s-Ship, which is 243 
exclusively expressed in cap cells during puberty, correlates with enhanced mammary repopulating capacity 244 
in limiting dilution transplantation assays [6]. In addition, s-Ship-expressing cap cells are strongly associated 245 
with the expression of Par3L, a protein related to the cell polarity regulator Par3, which is required for MaSC 246 
maintenance and ductal morphogenesis [60]. Recent mathematical modeling of mammary ductal elongation, 247 
however, suggests that inwardly-migrating cap cells do not contribute to the luminal epithelial lineage, as 248 
previously hypothesized [5]. Therefore, the precise contribution of these anatomically-distinct cells to ductal 249 
morphogenesis requires further investigation. The relationship between cap cells in the TEB and unipotent 250 
MaSCs, identified by genetic lineage-tracing [11,15,16,18], is also unclear. An answer to these important 251 
questions, and a potential unifying definition of physiological MaSC potency, awaits future inducible fate-252 
mapping studies using transgenic s-SHIP and/or Par3L reporter models. 253 
 254 
In the post-pubescent mammary gland, where TEBs have fully regressed, the location of MaSCs and their 255 
niche constituents is more ambiguous (Figure 1c). It is presumed that MaSCs, left behind by elongating TEBs 256 
during pubertal growth, are dispersed throughout the adult epithelial network. Here, hormonal cues stimulate 257 
further branching and the formation of alveolar-like buds and lobuloalveoli during estrous cycling and in 258 
pregnancy, respectively [61]. The notable absence of hormone receptors in mammary repopulating [62] and 259 
MaSC-enriched basal cell populations [63] implies that paracrine interactions between hormone receptor-260 
expressing cells and stem cells guide tissue development and homeostasis [64–68]. Multiple paracrine 261 
signaling pathways, including Wnt, EGFR, IGFR and RANK signaling, are reported to regulate MaSC 262 
function downstream of hormone action. In addition, FGF, Hedgehog and Notch signaling have also been 263 
implicated in modulating MaSC fate during different stages of mammary gland development. How the local 264 
activities of these pathways are controlled by systemic changes in hormone levels, however, remains unknown 265 
[69,70]. Nevertheless, the widespread distribution of hormone receptor-positive cells throughout the adult 266 
mammary epithelial tree [16,71], suggests that MaSCs would be able to receive and integrate these paracrine 267 
signals at most architectural locations within the ductal epithelium. Moreover, alterations in the abundance 268 
and distribution of hormone receptor-positive cells with age [71], may reflect lifetime-dependent variations in 269 
a putative MaSC niche.  270 
 271 
MaSCs are thought to survive tissue remodeling during post-lactational involution, enabling further cycles of 272 
expansion with each subsequent pregnancy (Figure 1c-f). It is therefore tempting to speculate that MaSCs 273 
reside in the vicinity of epithelial branch points, poised to generate the lateral branches and lobuloalveolar 274 
structures required for lactation. Fate-mapping studies using an alveolar-specific whey acidic protein (WAP)-275 
driven Cre have also identified a population of long-lived parity induced-mammary epithelial cells (PI-MECs) 276 
that are sustained through multiple reproductive cycles [72]. These cells reside at ductal extremities in the 277 
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post-parous mammary gland, and contribute exclusively to the hormone receptor-negative luminal lineage in 278 
subsequent pregnancies [7,72]. Intriguingly, a recent single cell lineage-tracing study has revealed unequal 279 
distribution of MaSC progeny between lobuloalveolar units in lactating mammary tissue [16]. Thus, these 280 
striking observations also support a model whereby an alveolar stem cell niche is positioned near bifurcation 281 
sites in the mature ductal epithelium. Interestingly, increased MaSC activity during pregnancy correlates with 282 
the re-expression of s-Ship specifically in basal cells at the tips of alveolar buds, suggesting the emergence of 283 
a transient stem cell niche during lobuloalveologenesis [6].  284 
 285 
MaSC niche dynamics 286 
As described earlier in this review, distinct adult MaSCs are postulated to fulfil the proliferative and 287 
homeostatic demands of the mammary gland (Figure 4) [19]. The degree to which the heterogeneity in the 288 
MaSC compartment is intrinsic or a result of microenvironmental cues, however, is not known. A recent single 289 
cell lineage-tracing study, which employed quantitative volumetric analysis to determine the contribution of 290 
a single labeled MaSC to ductal morphogenesis, estimated that at least 35 lineage-restricted MaSCs actively 291 
and stochastically contribute to the development of each major duct during puberty [16]. A subsequent study, 292 
also using quantitative lineage-tracing at clonal density, put this number at 260 lineage-restricted MaSCs per 293 
TEB, leading to the suggestion that most TEB cells can function as lineage-committed MaSCs [18]. 294 
Discrepancies between these two studies may reflect differing functional definitions of MaSCs, and the 295 
quantitative and mathematical platforms and assumptions for analysis. Quantitative lineage-tracing studies 296 
also suggest that molecularly heterogeneous populations of TEB-resident MaSCs function as single equipotent 297 
pools, colonizing ductal branches through stochastic neutral drift dynamics [18]. Random segregation during 298 
successive rounds of TEB bifurcation mediates the unequal distribution of MaSC progeny between adjacent 299 
ductal structures, leading to clonal enrichment or extinction over time [18], supporting previous observations 300 
of clonal labeling patterns [16]. Furthermore, single cell lineage-tracing has shown that most lactational alveoli 301 
are comprised of the progeny of more than a single unipotent MaSC, indicating that a pool of lineage-restricted 302 
alveolar MaSCs also contribute to alveolar morphogenesis during pregnancy and lactation [16]. These early 303 
applications of quantitative and single-cell lineage-tracing approaches in the mammary gland [16,18] have 304 
provided unprecedented insights into clonal dynamics and stem/progenitor heterogeneity and multiplicity, 305 
heralding a new era in our investigation and understanding of normal and malignant stem cells in the breast. 306 
 307 
Concluding Remarks  308 
In this review we examined properties of potency, dynamics and plasticity in adult MaSCs, and the respective 309 
technologies that have underpinned key experimental observations. Whilst this area has received considerable 310 
attention over the last decade, many questions remain unanswered (see Outstanding Questions). At the center 311 
of this enquiry is whether MaSCs in the adult breast are unipotent, bipotent or something less discordant.   312 
 313 
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Stem cells are defined by their functional abilities, that is: proliferation, self-maintenance, production of a 314 
large number of differentiated progeny, tissue regeneration/repair, and a flexibility within these states [39]. 315 
The challenge thus far has been how to study a cell’s functionality without inadvertently altering its function. 316 
Lineage-tracing has come a long way in this respect [11–16,18]. The refinement of lineage-tracing approaches 317 
and the application of other novel experimental models and methods for marking, visualizing and profiling 318 
individual cells (Box 1) will continue to provide important insights in this field. The question then becomes, 319 
what level of evidence is required to achieve a consensus?  320 
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Glossary  328 
Basal cell: one of the two main cell lineages in the mammary gland; basal cells surround the luminal cell layer 329 
and typically express cytokeratin-5, -14 and smooth muscle actin. 330 
Bi/multipotent: able to give rise to more than one cell lineage, e.g., a bipotent MaSC may be able to give rise 331 
to both basal and luminal progeny. 332 
Clone: All of the progeny of a single parent cell. 333 
Label retaining cell: a cell that is able to retain a label (be it a lipophilic dye, DNA intercalating nucleoside 334 
or regulated-expression of a fluorescently-tagged histone) over a defined chase period. Cells that remain in 335 
cycle dilute the label, whereas slow-cycling or quiescent cells remain labeled at the end of the assay. 336 
Lineage-tracing: a technique to identify the progeny of a single cell; the phrase “population-based lineage-337 
tracing” has been used here to distinguish techniques that trace the progeny of specific populations of cells 338 
(e.g., cytokeratin-14-expressing cells) generally at levels higher than clonal density.  339 
Luminal cell: one of the two main cell lineages in the mammary gland; luminal cells line the lumen of ducts 340 
and alveoli; they typically express cytokeratin-8 and may be hormone receptor positive or negative. 341 
Mammary epithelial cell hierarchy: the organization of stem, progenitor and differentiated cells in the 342 
mammary gland. 343 
Mammary repopulating cells: Cells enriched for the ability to regenerate the mammary epithelium upon 344 
serial transplantation at limiting dilution into the cleared fat pad of a recipient mouse. 345 
Mammary stem cells (MaSCs): undifferentiated cells in the mammary gland that are capable of giving rise 346 
indefinitely to more stem cells (self-renewal) as well as to more-differentiated daughters through symmetric 347 
and asymmetric divisions. Uncertainties surrounding the identity, differentiation potential and plasticity of 348 
these cells has generated semantic debate, and MaSCs are also referred to more conservatively as 349 
“stem/progenitor cells”.  350 
Potential stem cell: a more differentiated cell that is able to re-acquire stem-like properties under 351 
regenerative/wounding conditions. Also known as facultative stem cells. 352 
Stem cell niche: the specialized microenvironment in which a stem cell resides that can regulate stem cell 353 
self-renewal, differentiation and longevity.  354 
Terminal end bud (TEB): bulbous proliferative structures at the ends of each main duct during puberty; the 355 
presumptive location of pubertal MaSCs. 356 
Unipotent: able to give rise to one main cell lineage, e.g., a unipotent luminal stem cell is able to give rise 357 
only to luminal progeny and a unipotent basal stem cell is able to give rise only to basal progeny.  358 
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Figure Legends  359 
Figure 1: Postnatal mammary gland development in mice. a) Mammals are born with only a rudimentary 360 
ductal structure (see [3] and [4] for a description of embryonic mammary gland development), which begins 361 
to elongate and invade the empty fat pad at puberty (b). By the end of puberty (c), the ductal structures have 362 
reached the boundaries of the mammary fat-pad and the TEBs have fully regressed. Mammary ducts are 363 
comprised of two epithelial cell lineages arranged into distinct cell layers; luminal cells line the lumen of each 364 
duct and are surrounded by an outer layer of basal cells (depicted inset). Whether MaSCs in the adult 365 
mammary gland are lineage-restricted or can give rise to both luminal and basal cells is area of contention. c-366 
e) Resident MaSCs in the mature mammary epithelium are responsible for the generation of milk-producing 367 
alveoli during pregnancy and lactation. f) Stem cells are likely to survive post-lactational regression 368 
(involution) to enable successive pregnancies. The mouse is an excellent model for studying processes 369 
regulating human mammary gland development and tumorigenesis, however, key differences exist (see [83]). 370 
Notably, the human mammary gland is arranged in distinct lobes, each with a separate ductal structure and 371 
outlet.  372 
 373 
Figure 2: A summary of the key discoveries in the field and the methodologies that enabled these 374 
advances. This timeline focuses on discoveries made within the last decade, using transplantation or genetic 375 
lineage-tracing assays. For a more detailed historical review see [19,20,84]. Schematic diagrams summarizing 376 
each in vivo methodology are depicted at puberty, however, these techniques have also been utilized to assess 377 
cell fate at other developmental stages, and in some cases their use has also been extended to investigate 378 
cellular dynamics in mammary tumorigenesis. 379 
 380 
Figure 3: Limitations of population-based lineage-tracing studies. a) Clonal patterns arising from the 381 
genetic labeling of a single cell (purple). These studies demonstrate that progeny of a single marked cell can 382 
be distributed throughout the length of the ductal epithelium in a stochastic, interspersed labeling pattern. 383 
These patterns are likely to be caused by the proliferation of both labeled and unlabeled TEB-resident stem 384 
cells, which deposit their progeny throughout the epithelium during ductal elongation. Labeling patterns can 385 
extend more than 8 mm in linear length and comprise many side branches, highlighting the importance of 386 
performing 3D imaging and/or macro clone analysis. Scale bar: 0.2 mm. Adapted from Lloyd-Lewis et al. 387 
Breast Cancer Research (Springer Nature) [24]. A schematic representation of these labeling patterns in 388 
luminal and basal clones is shown in (b). The extensive and stochastic dispersion of stem cell progeny increase 389 
the likelihood of clone convergence in studies where labeling is performed above clonal density. Clone 390 
convergence is particularly evident when using a multi-color reporter gene. In the example here (b, bottom 391 
panel), it is difficult to distinguish whether luminal and basal blue cells came from a single bipotent precursor, 392 
or whether they arose from separate labeling events. Other technical limitations of population-based lineage-393 
tracing approaches include periodic and promiscuous labeling by pathway-specific or pan-lineage promoters. 394 
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 395 
Figure 4: A working model of the mammary epithelial cell hierarchy. Multipotent MaSCs are present in 396 
the embryo. Although the exact stage of lineage-specification is not clear, postnatal mammary gland 397 
development (i.e. ductal and alveolar morphogenesis) is principally driven by unipotent luminal and basal 398 
MaSCs. Luminal stem cells give rise to ductal and alveolar cells that can be estrogen receptor (ER) positive 399 
or negative. The extent of sub-lineage diversity in the basal compartment, and whether there are distinct ductal 400 
and alveolar basal cells, is not yet clear. In addition to the cells responsible for building mammary ducts and 401 
alveoli under physiological conditions (left panel), various studies indicate that quiescent and potential stem 402 
cells may also reside within the adult mammary gland (right panel). Quiescent bi/multipotent MaSCs (not 403 
detected by quantitative or single cell lineage-tracing approaches) may remain in the mammary gland after 404 
embryonic development. Additionally, a plastic, intermediate cell type with properties similar to the basal cell 405 
lineage may be capable of reverting to a multipotent state under regenerative conditions. Lineage-restricted 406 
luminal and basal progenitors have also been shown to reacquire multipotency with oncogenic 407 
reprogramming. A holistic description of the cellular differentiation hierarchy in the mammary gland may 408 
need to accommodate aspects of plasticity.   409 
 410 
 411 
  412 
15 
 
References  413 
1  Visvader, J.E. and Clevers, H. (2016) Tissue-specific designs of stem cell hierarchies. Nat. Cell Biol. 414 
18, 349–355 415 
2  O’Brien, L.E. and Bilder, D. (2013) Beyond the niche: tissue-level coordination of stem cell 416 
dynamics. Annu. Rev. Cell Dev. Biol. 29, 107–36 417 
3  Macias, H. and Hinck, L. (2012) Mammary gland development. Wiley Interdiscip. Rev. Dev. Biol. 1, 418 
533–557 419 
4  Watson, C.J. and Khaled, W.T. (2008) Mammary development in the embryo and adult: a journey of 420 
morphogenesis and commitment. Development 135, 995–1003 421 
5  Paine, I. et al. (2016) A geometrically-constrained mathematical model of mammary gland ductal 422 
elongation reveals novel cellular dynamics within the terminal end bud. PLoS Comput. Biol. 12, 423 
e1004839 424 
6  Bai, L. and Rohrschneider, L.R. (2010) s-SHIP promoter expression marks activated stem cells in 425 
developing mouse mammary tissue. Genes Dev. 24, 1882–1892 426 
7  Chang, T.H.-T. et al. (2014) New insights into lineage restriction of mammary gland epithelium using 427 
parity-identified mammary epithelial cells. Breast Cancer Res. 16, R1 428 
8  Stingl, J. et al. (2006) Purification and unique properties of mammary epithelial stem cells. Nature 429 
439, 993–7 430 
9  Shackleton, M. et al. (2006) Generation of a functional mammary gland from a single stem cell. 431 
Nature 439, 84–8 432 
10  Sleeman, K.E. et al. (2006) CD24 staining of mouse mammary gland cells defines luminal epithelial, 433 
myoepithelial/basal and non-epithelial cells. Breast Cancer Res. 8, R7 434 
11  Van Keymeulen, A. et al. (2011) Distinct stem cells contribute to mammary gland development and 435 
maintenance. Nature 479, 189–193 436 
12  de Visser, K.E. et al. (2012) Developmental stage-specific contribution of LGR5(+) cells to basal and 437 
luminal epithelial lineages in the postnatal mammary gland. J. Pathol. 228, 300–9 438 
13  van Amerongen, R. et al. (2012) Developmental stage and time dictate the fate of Wnt/β-catenin-439 
responsive stem cells in the mammary gland. Cell Stem Cell 11, 387–400 440 
14  Rios, A.C. et al. (2014) In situ identification of bipotent stem cells in the mammary gland. Nature 441 
506, 322–7 442 
15  Wuidart, A. et al. (2016) Quantitative lineage tracing strategies to resolve multipotency in tissue-443 
specific stem cells. Genes Dev. 30, 1261–77 444 
16  Davis, F.M. et al. (2016) Single-cell lineage tracing in the mammary gland reveals stochastic clonal 445 
dispersion of stem/progenitor cell progeny. Nat. Commun. 7, 13053 446 
17  Wang, D. et al. (2015) Identification of multipotent mammary stem cells by protein C receptor 447 
expression. Nature 517, 81–4 448 
16 
 
18  Scheele, C. et al. (2017) Identity and dynamics of mammary stem cells during branching 449 
morphogenesis. Nature  450 
19  Sreekumar, A. et al. (2015) The mammary stem cell hierarchy: a looking glass into heterogeneous 451 
breast cancer landscapes. Endocr. Relat. Cancer 22, T161-76 452 
20  Visvader, J.E. and Stingl, J. (2014) Mammary stem cells and the differentiation hierarchy: current 453 
status and perspectives. Genes Dev. 28, 1143–1158 454 
21  Nassar, D. and Blanpain, C. (2016) Cancer stem cells: basic concepts and therapeutic implications. 455 
Annu. Rev. Pathol. Mech. Dis. 11, 47–76 456 
22  DeOme, K.B. et al. (1959) Development of mammary tumors from hyperplastic alveolar nodules 457 
transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 19, 515–20 458 
23  Rios, A.C. et al. (2016) Essential role for a novel population of binucleated mammary epithelial cells 459 
in lactation. Nat. Commun. 7, 11400 460 
24  Lloyd-Lewis, B. et al. (2016) Imaging the mammary gland and mammary tumours in 3D: optical 461 
tissue clearing and immunofluorescence methods. Breast Cancer Res. 18, 127 462 
25  Sale, S. and Pavelic, K. (2015) Mammary lineage tracing: The coming of age. Cell. Mol. Life Sci. 72, 463 
1577–1583 464 
26  Hoshino, K. (1964) Regeneration and growth of quantitatively transplanted mammary glands of 465 
normal female mice. Anat. Rec. 150, 221–36 466 
27  Smith, G.H. and Medina, D. (1988) A morphologically distinct candidate for an epithelial stem cell in 467 
mouse mammary gland. J. Cell Sci. 90 ( Pt 1), 173–183 468 
28  Daniel, C. et al. (1968) The in vivo life span of normal and preneoplastic mouse mammary glands: a 469 
serial transplantation study. Proc. Natl. Acad. Sci. U. S. A. 61, 53–60 470 
29  Kordon, E.C. and Smith, G.H. (1998) An entire functional mammary gland may comprise the 471 
progeny from a single cell. Development 125, 1921–30 472 
30  Ehmann, U.K. et al. (1987) Cultured mouse mammary epithelial cells: normal phenotype after 473 
implantation. J. Natl. Cancer Inst. 78, 751–7. 474 
31  Smith, G.H. (1996) Experimental mammary epithelial morphogenesis in an in vivo model: Evidence 475 
for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res. Treat. 39, 476 
21–31 477 
32  Prater, M.D. et al. (2014) Mammary stem cells have myoepithelial cell properties. Nat. Cell Biol. 16, 478 
942–50, 1–7 479 
33  Van Keymeulen, A. et al. (2015) Reactivation of multipotency by oncogenic PIK3CA induces breast 480 
tumour heterogeneity. Nature 525, 119–123 481 
34  Koren, S. et al. (2015) PIK3CA(H1047R) induces multipotency and multi-lineage mammary 482 
tumours. Nature 525, 114–118 483 
35  Rios, A.C. et al. (2016) The complexities and caveats of lineage tracing in the mammary gland. 484 
17 
 
Breast Cancer Res. 18, 116 485 
36  Rodilla, V. et al. (2015) Luminal Progenitors Restrict Their Lineage Potential during Mammary 486 
Gland Development. PLoS Biol. 13,  487 
37  Lafkas, D. et al. (2013) Notch3 marks clonogenic mammary luminal progenitor cells in vivo. J. Cell 488 
Biol. 203, 47–56 489 
38  Kozar, S. et al. (2013) Continuous clonal labeling reveals small numbers of functional stem cells in 490 
intestinal crypts and adenomas. Cell Stem Cell 13, 626–33 491 
39  Potten, C.S. and Loeffler, M. (1990) Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. 492 
Lessons for and from the crypt. Development 110, 1001–1020 493 
40  Aloia, L. et al. (2016) Cellular plasticity in the adult liver and stomach. J. Physiol. 594, 4815–25 494 
41  Cotsarelis, G. et al. (1990) Label-retaining cells reside in the bulge area of pilosebaceous unit: 495 
implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61, 1329–37 496 
42  Horsley, V. et al. (2008) NFATc1 balances quiescence and proliferation of skin stem cells. Cell 132, 497 
299–310 498 
43  Tumbar, T. et al. (2004) Defining the epithelial stem cell niche in skin. Science 303, 359–63 499 
44  Buczacki, S.J.A. et al. (2013) Intestinal label-retaining cells are secretory precursors expressing Lgr5. 500 
Nature 495, 65–69 501 
45  Ito, M. et al. (2005) Stem cells in the hair follicle bulge contribute to wound repair but not to 502 
homeostasis of the epidermis. Nat. Med. 11, 1351–1354 503 
46  Boras-Granic, K. et al. (2014) Embryonic cells contribute directly to the quiescent stem cell 504 
population in the adult mouse mammary gland. Breast Cancer Res. 16, 487 505 
47  Li, L. and Clevers, H. (2010) Coexistence of quiescent and active adult stem cells in mammals. 506 
Science 327, 542–5 507 
48  Fuchs, E. and Horsley, V. (2011) Ferreting out stem cells from their niches. Nat. Cell Biol. 13, 513–508 
518 509 
49  dos Santos, C.O. et al. (2013) Molecular hierarchy of mammary differentiation yields refined markers 510 
of mammary stem cells. Proc. Natl. Acad. Sci. U. S. A. 110, 7123–30 511 
50  Cai, S. et al. (2017) A quiescent Bcl11b high stem cell population is required for maintenance of the 512 
mammary gland. Cell Stem Cell 20, 247–60 513 
51  Fu, N. et al. (2017) Identification of quiescent and spatially restricted mammary stem cells that are 514 
hormone responsive. Nat. Cell Biol. 19, 164–76 515 
52  Giraddi, R.R. et al. (2015) Stem and progenitor cell division kinetics during postnatal mouse 516 
mammary gland development. Nat. Commun. 6, 8487 517 
53  Inman, J.L. et al. (2015) Mammary gland development: cell fate specification, stem cells and the 518 
microenvironment. Development 142, 1028–1042 519 
54  Howard, B.A. and Lu, P. (2014) Stromal regulation of embryonic and postnatal mammary epithelial 520 
18 
 
development and differentiation. Semin. Cell Dev. Biol. 25–26, 43–51 521 
55  Young, L.J.T. et al. (1971) The influence of host and tissue age on life span and growth rate of 522 
serially transplanted mouse mammary gland. Exp. Gerontol. 6, 49–56 523 
56  Chepko, G. and Smith, G.H. (1997) Three division-competent, structurally-distinct cell populations 524 
contribute to murine mammary epithelial renewal. Tissue Cell 29, 239–253 525 
57  Chepko, G. and Dickson, R.B. (2003) Ultrastructure of the putative stem cell niche in rat mammary 526 
epithelium. Tissue Cell 35, 83–93 527 
58  Williams, J.M. and Daniel, C.W. (1983) Mammary ductal elongation: differentiation of 528 
myoepithelium and basal lamina during branching morphogenesis. Dev. Biol. 97, 274–90 529 
59  Srinivasan, K. et al. (2003) Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells 530 
during mammary gland morphogenesis. Dev. Cell 4, 371–382 531 
60  Huo, Y. and Macara, I.G. (2014) The Par3-like polarity protein Par3L is essential for mammary stem 532 
cell maintenance. Nat. Cell Biol. 16, 529–537 533 
61  Brisken, C. and O’Malley, B. (2010) Hormone action in the mammary gland. Cold Spring Harb. 534 
Perspect. Biol. 2, a003178 535 
62  Sleeman, K.E. et al. (2007) Dissociation of estrogen receptor expression and in vivo stem cell activity 536 
in the mammary gland. J. Cell Biol. 176, 19–26 537 
63  Asselin-Labat, M.-L. et al. (2006) Steroid hormone receptor status of mouse mammary stem cells. J. 538 
Natl. Cancer Inst. 98, 1011–1014 539 
64  Beleut, M. et al. (2010) Two distinct mechanisms underlie progesterone-induced proliferation in the 540 
mammary gland. Proc. Natl. Acad. Sci. U. S. A. 107, 2989–94 541 
65  Asselin-Labat, M.-L. et al. (2010) Control of mammary stem cell function by steroid hormone 542 
signalling. Nature 465, 798–802 543 
66  Cai, C. et al. (2014) R-spondin1 is a novel hormone mediator for mammary stem cell self-renewal. 544 
Genes Dev. 28, 2205–2218 545 
67  Rajaram, R.D. et al. (2015) Progesterone and Wnt4 control mammary stem cells via myoepithelial 546 
crosstalk. EMBO J. 34, 641–652 547 
68  Joshi, P. a et al. (2010) Progesterone induces adult mammary stem cell expansion. Nature 465, 803–7 548 
69  Rosen, J.M. and Roarty, K. (2014) Paracrine signaling in mammary gland development: what can we 549 
learn about intratumoral heterogeneity? Breast Cancer Res. 16, 202 550 
70  Brisken, C. and Ataca, D. (2015) Endocrine hormones and local signals during the development of 551 
the mouse mammary gland. Wiley Interdiscip. Rev. Dev. Biol. 4, 181–195 552 
71  Ismail, P.M. et al. (2002) A novel LacZ reporter mouse reveals complex regulation of the 553 
progesterone receptor promoter during mammary gland development. Mol. Endocrinol. 16, 2475–89 554 
72  Wagner, K.-U. et al. (2002) An adjunct mammary epithelial cell population in parous females: its role 555 
in functional adaptation and tissue renewal. Development 129, 1377–86 556 
19 
 
73  Tainaka, K. et al. (2014) Whole-body imaging with single-cell resolution by tissue decolorization. 557 
Cell 159, 911–924 558 
74  Ke, M.-T. et al. (2013) SeeDB: a simple and morphology-preserving optical clearing agent for 559 
neuronal circuit reconstruction. Nat. Neurosci. 16, 1154–61 560 
75  Davis, F.M. et al. (2015) Essential role of Orai1 store-operated calcium channels in lactation. Proc. 561 
Natl. Acad. Sci. U. S. A. 112, 5827–32 562 
76  Ritsma, L. et al. (2013) Surgical implantation of an abdominal imaging window for intravital 563 
microscopy. Nat. Protoc. 8, 583–94 564 
77  Zomer, A. et al. (2013) Intravital imaging of cancer stem cell plasticity in mammary tumors. Stem 565 
Cells 31, 602–6 566 
78  Kumar, P. et al. (2017) Understanding development and stem cells using single cell-based analyses of 567 
gene expression. Development 144, 17–32 568 
79  McKenna, A. et al. (2016) Whole-organism lineage tracing by combinatorial and cumulative genome 569 
editing. Science 353, aaf7907 570 
80  Perli, S.S.D. et al. (2016) Continuous genetic recording with self-targeting CRISPR-Cas in human 571 
cells. Science 511, 53058 572 
81  Clevers, H. (2016) Modeling Development and Disease with Organoids. Cell 165, 1586–97 573 
82  Jardé, T. et al. (2016) Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone 574 
responsive mammary organoids. Nat. Commun. 7, 13207 575 
83  Cardiff, R.D. and Wellings, S.R. (1999) The comparative pathology of human and mouse mammary 576 
glands. J. Mammary Gland Biol. Neoplasia 4, 105–122 577 
84  Oakes, S.R. et al. (2014) The mammary cellular hierarchy and breast cancer. Cell. Mol. Life Sci. 71, 578 
4301–4324 579 
 580 
